Trade Capricor Therapeutics Inc - CAPR CFD
What is Capricor Therapeutics Inc (CAPR)?
Capricor Therapeutics Inc is a biotechnology company dedicated to the development of cell and exosome-based therapies for cardiovascular and rare diseases. The company focuses on regenerative medicine approaches to treat conditions such as heart failure and muscular dystrophy. Capricor Therapeutics Inc conducts research and clinical trials to evaluate the safety and efficacy of its therapeutic candidates. It utilizes proprietary technologies in cell isolation and manufacturing to support its product development. The company aims to address unmet medical needs through innovative biologic treatments.
Capricor Therapeutics Inc Stock Price Today: Live Overview
The price today is shaped by market movements, with Lonza Group Ltd trading at $29.89. Today’s price has fluctuated within the range of $27.95 to $30.4, showing a daily change percentage of +7.7922%.
FAQ: Capricor Therapeutics Inc (CAPR)
What is the current price of CAPR stock?
Capricor Therapeutics Inc is trading at $29.89 currently.
Does CAPR pay dividends?
Capricor Therapeutics Inc does not pay dividends at this time.
Does CAPR have a formal corporate presence or regional headquarters in the UAE?
Capricor Therapeutics Inc has no official presence in the UAE and operates through distributors.
What is CAPR best known for?
Capricor Therapeutics Inc is most famous for its development of cell and exosome-based therapies.
What assets are typically shown together with CAPR?
Commonly shown alongside CAPR: Baidu Inc - ADR, Integer Holdings Corp, Barclays
Latest shares articles



